ZOETIS INC (1ZTS.MI) Fundamental Analysis & Valuation

BIT:1ZTS • US98978V1035

Current stock price

99.23 EUR
-10.43 (-9.51%)
Last:

This 1ZTS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1ZTS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ZTS was profitable.
  • 1ZTS had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1ZTS has been profitable.
  • In the past 5 years 1ZTS always reported a positive cash flow from operatings.
1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCF1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of 1ZTS (17.28%) is better than 92.31% of its industry peers.
  • 1ZTS has a Return On Equity of 80.25%. This is amongst the best in the industry. 1ZTS outperforms 98.08% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 21.95%, 1ZTS belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ZTS is above the industry average of 17.75%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1ZTS.MI Yearly ROA, ROE, ROIC1ZTS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • 1ZTS's Profit Margin of 28.23% is amongst the best of the industry. 1ZTS outperforms 88.46% of its industry peers.
  • 1ZTS's Profit Margin has improved in the last couple of years.
  • 1ZTS has a better Operating Margin (38.54%) than 92.31% of its industry peers.
  • 1ZTS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 71.89%, 1ZTS is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • 1ZTS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
1ZTS.MI Yearly Profit, Operating, Gross Margins1ZTS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1ZTS.MI Health Analysis

2.1 Basic Checks

  • 1ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1ZTS has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1ZTS has been reduced compared to 5 years ago.
  • The debt/assets ratio for 1ZTS is higher compared to a year ago.
1ZTS.MI Yearly Shares Outstanding1ZTS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
1ZTS.MI Yearly Total Debt VS Total Assets1ZTS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.39 indicates that 1ZTS is not in any danger for bankruptcy at the moment.
  • 1ZTS has a better Altman-Z score (5.39) than 78.85% of its industry peers.
  • The Debt to FCF ratio of 1ZTS is 3.96, which is a good value as it means it would take 1ZTS, 3.96 years of fcf income to pay off all of its debts.
  • 1ZTS's Debt to FCF ratio of 3.96 is in line compared to the rest of the industry. 1ZTS outperforms 57.69% of its industry peers.
  • A Debt/Equity ratio of 2.71 is on the high side and indicates that 1ZTS has dependencies on debt financing.
  • 1ZTS's Debt to Equity ratio of 2.71 is on the low side compared to the rest of the industry. 1ZTS is outperformed by 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.39
ROIC/WACC2.45
WACC8.97%
1ZTS.MI Yearly LT Debt VS Equity VS FCF1ZTS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.03 indicates that 1ZTS has no problem at all paying its short term obligations.
  • The Current ratio of 1ZTS (3.03) is better than 90.38% of its industry peers.
  • 1ZTS has a Quick Ratio of 1.94. This is a normal value and indicates that 1ZTS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of 1ZTS (1.94) is better than 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
1ZTS.MI Yearly Current Assets VS Current Liabilites1ZTS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ZTS.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.45% over the past year.
  • 1ZTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.77% yearly.
  • Looking at the last year, 1ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • The Revenue is expected to grow by 5.30% on average over the next years.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1ZTS.MI Yearly Revenue VS Estimates1ZTS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1ZTS.MI Yearly EPS VS Estimates1ZTS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1ZTS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.94, which indicates a rather expensive current valuation of 1ZTS.
  • The rest of the industry has a similar Price/Earnings ratio as 1ZTS.
  • 1ZTS is valuated rather cheaply when we compare the Price/Earnings ratio to 25.51, which is the current average of the S&P500 Index.
  • 1ZTS is valuated correctly with a Price/Forward Earnings ratio of 16.27.
  • Based on the Price/Forward Earnings ratio, 1ZTS is valued a bit cheaper than the industry average as 67.31% of the companies are valued more expensively.
  • 1ZTS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.94
Fwd PE 16.27
1ZTS.MI Price Earnings VS Forward Price Earnings1ZTS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ZTS is on the same level as its industry peers.
  • 1ZTS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.29
EV/EBITDA 13.38
1ZTS.MI Per share data1ZTS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • 1ZTS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1ZTS may justify a higher PE ratio.
PEG (NY)1.75
PEG (5Y)1.67
EPS Next 2Y8.92%
EPS Next 3Y8.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. 1ZTS.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.64%, 1ZTS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.95, 1ZTS has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1ZTS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of 1ZTS is nicely growing with an annual growth rate of 20.56%!
Dividend Growth(5Y)20.56%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 33.26% of the earnings are spent on dividend by 1ZTS. This is a low number and sustainable payout ratio.
  • The dividend of 1ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
1ZTS.MI Yearly Income VS Free CF VS Dividend1ZTS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1ZTS.MI Dividend Payout.1ZTS.MI Dividend Payout, showing the Payout Ratio.1ZTS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ZTS.MI Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

BIT:1ZTS (3/23/2026, 7:00:00 PM)

99.23

-10.43 (-9.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners100.79%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap41.89B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target132.47 (33.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.77
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)0%
PT rev (3m)-9.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 17.94
Fwd PE 16.27
P/S 5.13
P/FCF 21.29
P/OCF 16.74
P/B 14.59
P/tB N/A
EV/EBITDA 13.38
EPS(TTM)5.53
EY5.57%
EPS(NY)6.1
Fwd EY6.15%
FCF(TTM)4.66
FCFY4.7%
OCF(TTM)5.93
OCFY5.97%
SpS19.33
BVpS6.8
TBVpS-0.89
PEG (NY)1.75
PEG (5Y)1.67
Graham Number29.09
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.39
F-Score6
WACC8.97%
ROIC/WACC2.45
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / 1ZTS.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOETIS INC (1ZTS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 4 / 10 to ZOETIS INC (1ZTS.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ZOETIS INC?

ZOETIS INC (1ZTS.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for 1ZTS stock?

The Price/Earnings (PE) ratio for ZOETIS INC (1ZTS.MI) is 17.94 and the Price/Book (PB) ratio is 14.59.


What is the earnings growth outlook for ZOETIS INC?

The Earnings per Share (EPS) of ZOETIS INC (1ZTS.MI) is expected to grow by 10.25% in the next year.